Health
Oxford/AstraZeneca vaccine: rare blood clot syndrome has high mortality rate – The Guardian
Researchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people
CoronavirusResearchers found that clots occurring after first dose of Oxford jab affected otherwise young and healthy people
Although extremely rare, a blood clot syndrome after the first dose of the Oxford/AstraZeneca vaccine carries a high risk of death…
Continue Reading